Medicine and Dentistry
Rheumatoid Arthritis
100%
Disease Activity
45%
Spondylarthritis
31%
Patient-Reported Outcome
26%
Biological Product
25%
Disease Modifying Antirheumatic Drug
25%
Tocilizumab
22%
Psoriatic Arthritis
19%
TNF Inhibitor
17%
Randomized Controlled Trial
16%
Drug Dose Reduction
13%
Spontaneous Remission
13%
Rheumatic Disease
12%
Systemic Lupus Erythematosus
12%
Meta-Analysis
12%
Systematic Review
12%
Clinical Trial
12%
COVID-19
12%
Abatacept
12%
Drug Antibody
12%
Clinical Disease Activity Index
9%
Odds Ratio
7%
Visual Analog Scale
7%
Outpatient
6%
Short Form 36
6%
BASDAI
5%
Nursing and Health Professions
Rheumatoid Arthritis
37%
Patient-Reported Outcome
26%
Confidence Interval
25%
Spondylarthritis
16%
Disease Activity
13%
Meta Analysis
12%
Systematic Review
12%
Biological Product
12%
Disease Modifying Antirheumatic Drug
12%
Rheumatic Disease
12%
Pandemic
12%
Odds Ratio
7%
Visual Analog Scale
7%
Short Form 36
6%
Bath Ankylosing Spondylitis Disease Activity Index
5%
Outpatient
5%
Tumor Necrosis Factor Inhibitor
5%
Pharmacology, Toxicology and Pharmaceutical Science
Rheumatoid Arthritis
25%
Rheumatic Disease
25%
Disease Activity
20%
Psoriatic Arthritis
16%
Spondylarthritis
16%
Disease Modifying Antirheumatic Drug
12%
Pandemic
12%
Cohort Study
12%
Randomized Controlled Trial
12%
Ankylosing Spondylitis
6%
Infection
5%
